Skip to main content

Find Clinical Trials

Home
Conditions
Diabetes Mellitus, Type 2

Clinical trial condition

Diabetes Mellitus, Type 2

Explore clinical trials studying Diabetes Mellitus, Type 2. Study availability and eligibility vary by location and protocol.

2,679 public trials 158 recruiting studies

Refine in advanced search Browse all conditions

Diabetes Mellitus, Type 2 trial results

Completed

Effects of Physical Activity Coaching on Health and Behaviour Parameters in Diabetic Persons

NCT02064335

Conditions: Behavior, Diabetes Mellitus, Diabetes Mellitus, Type 2, +4 more
Locations: KU Leuven Leuven, Vlaams Brabant, Belgium

View Trial Details

Completed

Evaluation of Pharmacokinetics, Safety, And Tolerability Of Ertugliflozin (PF-04971729, MK-8835) In Japanese And Western Healthy Participants (MK-8835-041)

NCT01223339

Conditions: Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +3 more
Locations: Not specified

View Trial Details

Completed

Defective Atypical Protein Kinase C (PKC) Activation in Diabetes and Metabolic Syndrome

NCT00690755

Conditions: Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +3 more
Locations: VA Medical Center Tampa, Florida, United States

View Trial Details

Completed

Correlation Between the Pulmonary Function Parameters and the Circulatory Parameters (PSV, EDV, RI) of Retrobulbar Blood Vessels (CRA, PCA, and OA) in 48 T2DM Patients Did Not Combinate With DR

NCT02774733

Conditions: Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +3 more
Locations: Not specified

View Trial Details

Completed

BI 10773 (Empagliflozin) Cardiovascular Outcome Event Trial in Type 2 Diabetes Mellitus Patients (EMPA-REG OUTCOME).

NCT01131676

Conditions: Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +3 more
Locations: 1245.25.10043 Boehringer Ingelheim Investigational Site Birmingham, Alabama, United States

1245.25.10121 Boehringer Ingelheim Investigational Site Birmingham, Alabama, United States

1245.25.10037 Boehringer Ingelheim Investigational Site Huntsville, Alabama, United States

1245.25.10124 Boehringer Ingelheim Investigational Site Mobile, Alabama, United States

View all 615 locations

View Trial Details

Completed

Promoting Healthy Habits With Elderlies Diabetics

NCT02771821

Conditions: Aged, Behavior, Diabetes Mellitus, +7 more
Locations: Federal University of Pernambuco Recife, Pernambuco, Brazil

View Trial Details

Completed

Efficacy of Self-hypnosis for Weight Loss in Type 2 Diabetics

NCT02769585

Conditions: Body Weight, Body Weight Changes, Diabetes Mellitus, +13 more
Locations: Not specified

View Trial Details

Completed

Interval-training in Type 2 Diabetics

NCT02320526

Conditions: Behavior, Diabetes Mellitus, Diabetes Mellitus, Type 2, +7 more
Locations: The Centre for Physical Activity Research, Rigshospitalet Copenhagen, Denmark

View Trial Details

Completed

Effects of Dapagliflozin on the Incretin Sensitivity of the Pancreatic Beta Cell

NCT02420392

Conditions: Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +3 more
Locations: Seoul National University Hospital Seoul, South Korea

View Trial Details

Completed

Efficacy and Safety of TAK-875 in Subjects With Type 2 Diabetes Mellitus

NCT01007097

Conditions: Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +3 more
Locations: Birmingham, Alabama, United States

Hoover, Alabama, United States

Tucson, Arizona, United States

Anaheim, California, United States

View all 71 locations

View Trial Details